Xuefang Cao

Associate Professor
Department of Immunology
Roswell Park Cancer Institute
United States of America

Academician Oncology
Biography

Dr. Xuefang Cao joined the faculty of Roswell Park Cancer Institute (RPCI) in December 2008 as an Assistant Member in the Department of Immunology. Dr. Cao earned a medical degree from Hebei Medical University in China in 1994 and a PhD degree from the University of Florida in 2003, and completed his postdoctoral fellowship in the Division of Oncology at Washington University in St. Louis. Dr. Cao has authored or co-authored more than 30 journal articles and abstracts.

Research Intrest

Cancer immunology and immune-based cancer therapy

List of Publications
Cao X, Leonard K, Collins LI, Cai SF, Mayer J, et al. (2009) IL-12 stimulates interferon-gamma mediated inhibition of tumor-induced regulatory T cell proliferation and enhances tumor clearance. Cancer Res 15;69: 8700-9
Cao X, Cai SF, Fehniger TA, Song J, Collins LI, et al. (2007) Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 27: 635-46.
Fehniger TA, Cai SF, Cao X, Bredemeyer AJ, Presti RM, et al. (2007) Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity 26: 798-811.